UK Favors Post-Brexit EMA/MHRA ‘Mutual Recognition’ Deal
Executive Summary
Jeremy Hunt, the UK Secretary of State for Health, has told a parliamentary committee that the EMA is likely to leave the UK but that his government will be seeking a close relationship with the agency that could involve the mutual recognition by the UK regulator of EU drug approvals.
You may also be interested in...
‘Virtually Bribery And Corruption Free’ Denmark With Its Clean Canals Says ‘Give Us EMA’
The UK is on track to start formal EU exit negotiations in March, Denmark has announced its official candidacy to host the European Medicines Agency post-Brexit, and details are emerging on the campaigns that other contenders for the EMA, such as Ireland and Italy, are waging.
Dutch Call For Early Decision On Location Of EMA And Say ‘Why Not Us?’
The Dutch government says it is well placed to host the European Medicines Agency, citing good travel links, the ability to host international organizations, and the prospect of continuity of the agency’s work. It wants a decision to be taken soon on the EMA’s future location.
Brexit: EMA Could Lose Up To Half Its Staff If It Has To Move
The European Medicines Agency is working to ensure it can cope with the many challenges it will face as a result of the UK leaving the EU. Those challenges could include the agency losing 50% of its staff, according to the EMA’s deputy head Noel Wathion.